KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacific Biosciences Of California (PACB) Current Deferred Revenue (2016 - 2025)

Historic Current Deferred Revenue for Pacific Biosciences Of California (PACB) over the last 16 years, with Q3 2025 value amounting to $16.0 million.

  • Pacific Biosciences Of California's Current Deferred Revenue fell 2960.96% to $16.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.0 million, marking a year-over-year decrease of 2960.96%. This contributed to the annual value of $13.9 million for FY2024, which is 1516.34% down from last year.
  • Pacific Biosciences Of California's Current Deferred Revenue amounted to $16.0 million in Q3 2025, which was down 2960.96% from $14.9 million recorded in Q2 2025.
  • Over the past 5 years, Pacific Biosciences Of California's Current Deferred Revenue peaked at $32.7 million during Q1 2023, and registered a low of $9.5 million during Q2 2021.
  • Over the past 5 years, Pacific Biosciences Of California's median Current Deferred Revenue value was $16.3 million (recorded in 2023), while the average stood at $20.2 million.
  • Per our database at Business Quant, Pacific Biosciences Of California's Current Deferred Revenue soared by 23652.19% in 2022 and then plummeted by 4641.62% in 2023.
  • Pacific Biosciences Of California's Current Deferred Revenue (Quarter) stood at $11.0 million in 2021, then skyrocketed by 177.84% to $30.5 million in 2022, then tumbled by 46.42% to $16.3 million in 2023, then dropped by 15.16% to $13.9 million in 2024, then increased by 15.76% to $16.0 million in 2025.
  • Its Current Deferred Revenue was $16.0 million in Q3 2025, compared to $14.9 million in Q2 2025 and $15.2 million in Q1 2025.